Kaiser Permanente research scientist and yoga teacher Ai Kubo harnesses a popular smartphone app to fulfill her longtime goal of spreading the benefits of mindfulness scientifically.
DOR's Theodore (TR) Levin, MD, is one of four recipients of The Permanente Medical Group's 2018 Sidney R. Garfield Exceptional Contribution Awards, for pioneering efforts to expand colorectal cancer screening.
Technology allows a panel of urologists and oncologists to provide the most up-to-date treatment for every single person with testicular cancer at Kaiser Permanente Northern California.
Researchers at the Kaiser Permanente Northern California Division of Research will lead a consortium evaluating colorectal cancer as part of the NCI’s Population-based Research to Optimize the Screening Process program.
New Kaiser Permanente study shows a better identification of low muscle and high fat might lead to better outcomes -Written by Jon Weiner A new study by Kaiser Permanente researchers is taking on the question of how muscle, and fat,…
Kaiser Permanente gastroenterologist answers 5 questions about his research into colon cancer, what sparked his interest, and things about the colon you may never have known.
Compared with the non-Hispanic white (NHW) population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer, according to results published by Kaiser Permanente researchers and colleagues in Cancer Research, a journal of the American Association for Cancer Research.
Alan Go, MD, of the Kaiser Permanente Division of Research, and Kaiser Permanente Northern California oncologist Louis Fehrenbacher, MD, are among the less than 400 people named as Highly Cited Researchers in clinical medicine for 2017 by Clarivate Analytics. The annual list recognizes investigators whose research ranks in the top 1 percent most cited works in their field, indicating exceptional scientific impact.
Patients with cancer often face barriers to optimal care, and Devon Check, PhD, a second-year Delivery Science Fellow in the Kaiser Permanente Division of Research, seeks to understand these hurdles inside and out.
Elizabeth “Betty” Suh-Burgmann, MD, says her latest research project was “born out of frustration with the state of affairs” for managing adnexal masses in women. Like gynecological oncologists across the nation, she saw many women at her Kaiser Permanente Walnut Creek practice undergo surgeries to determine whether small masses in their ovaries were benign or cancerous.